1-5 of 5
Nathaniel L. Baker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Plasma apoM Levels and Progression to Kidney Dysfunction in Patients With Type 1 Diabetes

Nathaniel L. Baker, Samar M. Hammad, Kelly J. Hunt, Andrea Semler, Richard L. Klein, Maria F. Lopes-Virella
Journal: Diabetes
Diabetes 2022;71(8):1795–1799
https://doi.org/10.2337/db21-0920
Published: 21 August 2022
View article titled, Plasma apoM Levels and Progression to Kidney Dysfunction in Patients With Type 1 Diabetes
Open the PDF for Plasma apoM Levels and Progression to Kidney Dysfunction in Patients With Type 1 Diabetes in another window
Journal Articles

Immune Complexes and the Risk of CVD in Type 1 Diabetes

Maria F. Lopes-Virella, Ionut Bebu, Kelly J. Hunt, Gabriel Virella, Nathaniel L. Baker, Barbara Braffett, Xiaoyu Gao, John M. Lachin, the DCCT/EDIC Research Group
Journal: Diabetes
Diabetes 2019;68(9):1853–1860
https://doi.org/10.2337/db19-0358
Published: 19 June 2019
View article titled, Immune Complexes and the Risk of CVD in Type 1 Diabetes
Open the PDF for Immune Complexes and the Risk of CVD in Type 1 Diabetes in another window
Includes: Supplementary data
Meeting Abstracts

445-P: Modified LDL-Immune Complexes (IC) and the Risk of CVD in Type 1 Diabetes

MARIA F. LOPES-VIRELLA, IONUT BEBU, KELLY J. HUNT, GABRIEL VIRELLA, NATHANIEL L. BAKER, BARBARA BRAFFETT, JOHN LACHIN, DCCT/EDIC RESEARCH GROUP
Journal: Diabetes
Diabetes 2019;68(Supplement_1):445-P
https://doi.org/10.2337/db19-445-P
Published: 01 June 2019
View article titled, 445-P: Modified LDL-Immune Complexes (IC) and the Risk of CVD in Type 1 Diabetes
Meeting Abstracts

Pro-apoptotic and Inflammatory Markers Enhance the Ability of MDA-LDL in Circulating Immune Complex to Predict Acute Myocardial Infarction in the VADT Study

MARIA F.L. LOPES-VIRELLA, KELLY J. HUNT, RASHI AGARWAL, NATHANIEL L. BAKER, GABRIEL VIRELLA, VADT INVESTIGATORS
Journal: Diabetes
Diabetes 2018;67(Supplement_1):430-P
https://doi.org/10.2337/db18-430-P
Published: 01 July 2018
View article titled, Pro-apoptotic and Inflammatory Markers Enhance the Ability of MDA-LDL in Circulating Immune Complex to Predict Acute Myocardial Infarction in the VADT Study
Journal Articles

Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes

Maria F. Lopes-Virella, Kelly J. Hunt, Nathaniel L. Baker, John Lachin, David M. Nathan, G. Virella, the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
Journal: Diabetes
Diabetes 2011;60(2):582–589
https://doi.org/10.2337/db10-0915
Published: 21 January 2011
View article titled, Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes
Open the PDF for Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes in another window